.png){kind=icon}
.png){kind=icon}
Return
The gut mycobiome and metabolic dysfunction in type 2 diabetes mellitus
.png){kind=icon}
PRE
AI
L
A
D
DOI：10.1016/j.diabres.2026.113456.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Gut mycobiome dysbiosis is associated with metabolic dysfunction in T2DM. • Candida enrichment is among the most frequently reported fungal alterations. • Experimental studies suggest fungal factors may promote barrier dysfunction. • Animal studies suggest early-life mycobiome may influence β-cell development. • Baseline fungal signatures may be associated with metabolic responses.
Journal
IF:
7.4
Papers:
1.1W
Citations:
2.2W
Organization
Cited Papers